In addition to her research interests, Dr. Anderson is the Medical Chief at the VA Medical Center; Program Director for the OHSU/VAMC Nephrology Fellowship program, and a member of several national organizations. She currently serves as Chair of the Nephrology Section of the American Board of Internal Medicine.

Degrees:

B.A., University of Maryland 1971
M.D., Louisiana State University Medical Center 1979

Residency:

Internal Medicine, Oregon Health Sciences University 1979-1982

Fellowship:

Nephrology - Beth Israel Hospital and Harvard Medical School, 1982-1983
Nephrology Research - Brigham and Women's Hospital and Harvard Medical School, 1983-1985

Research Interest:

• Hypertension and the kidney, Pathophysiology of the aging kidney, Diabetic nephropathy
• Hormonal modulation of renal function, and Mechanisms of progressive glomerular injury.

Clinical Interest:

Acute and chronic renal failure, hypertension, diabetic nephropathy.

Representative Publications:

• Anderson S, Jung FF, Ingelfinger JR. Renin-angiotensin system in diabetic rats: functional, immunohistochemical, and molecular biologic correlations. Am J Physiol 265:F477-F486, 1993
• Tank JE, Vora JP, Houghton DC, Anderson S. Altered renal vascular responses in the aging rat kidney. Am J Physiol. 1994;266;F942-F948.
• Kelly FJ, Anderson S, Thompson MM, Oyama TT, Kennifick TM, Corless CL, Roman RJ, Kurtzberg L, Pratt BM, Ledbetter SR. Acute and chronic renal effects of recombinant human TGF-_2 in the rat. J Am Soc Nephrol. 1999;10:1264-1273. Download PDF
• Kennefick TM, Al-Nimri MA, Oyama TT, Thompson MM, Kelly FJ, Chapman JG, Anderson S. Hypertension and renal injury in experimental polycystic kidney disease. Kidney Int. 1999; 56:2181-2190
• Thompson MM, Oyama TT, Kelly FJ, Kennefick TM, Anderson S. Activity and responsiveness of the renin-angiotensin system in the aging rat. Am J Physiol 279:R1787-R1794, 2000. Download PDF
• Komers R, Lindsley JN, Oyama TT, Allison KM, Anderson S. Role of neuronal nitric oxide synthase (NOS1) in the pathogenesis of renal hemodynamic changes in diabetes. Am J Physiol. 2000 Sep;279(3):F573-83. Download PDF
• Kang D-H, Anderson S, Kim Y-G, Mazzali M, Suga S-I, Jefferson JA, Gordon KL, Oyama TT, Hughes J, Hugo C, Kerjaschki D, Schreiner GF, Johnson RJ. Impaired angiogenesis in the aging kidney: vascular endothelial growth factor and thrombospondin-1 in renal disease. Am J Kidney Dis 37:601-611, 2001
• Komers R, Lindsley JN, Oyama TT, Schutzer WE, Reed JF, Mader SL, Anderson S. Immunohistochemical and functional correlations of renal cyclooxygenase-2 in experimental diabetes. J Clin Invest 197:889-898, 2001. Download PDF
• Komers R, Tian W, Lindsley JN, Oyama TT, Cohen DM, Anderson S. Effects of cyclooxygenase-2 (COX-2) inhibition on plasma and renal renin in diabetes. J Lab Clin Med 140:351-357, 2002
• Al-Nimri MA, Komers R, Oyama TT, Subramanya AR, Lindsley JN, Anderson S. Endothelial-derived vasoactive mediators in polycystic kidney disease. Kidney Int 63:1176-1784, 2003